Study period | |||||||
Process time point | Screening, enrolment and allocation | Preintervention (10 days) | Intervention | FU+4 hours | FU+1 day | FU+3 days | FU+30 days |
Screening, enrolment and allocation | |||||||
Eligibility screen | X | ||||||
Informed consent | X | ||||||
Baseline parameters | X | ||||||
Vital signs | X | X | X | X | X | X | |
Intervention | |||||||
Operative data | X | ||||||
RenalGuard | X | X | X | X | X | X | X |
Standard of care | X | X | X | X | X | X | X |
Assessment | |||||||
Urine biomarkers | X | ||||||
Serum creatinine | X | X | X | X | |||
Outcome measurements | |||||||
Primary | X | X | X | X | |||
Secondary | X | X | X | X | X |
FU, follow-up.